-+ 0.00%
-+ 0.00%
-+ 0.00%

BRIEF-Alx Oncology’S Evorpacept In Combination With Zanidatamab Generates Promising, Durable Response In Patients With Advanced Her2-Positive Breast Cancer And High Cd47 Expression

Reuters·05/07/2026 12:07:43

Please log in to view news